Maternal tetanus, diphtheria, and acellular pertussis (Tdap) and influenza immunization: an overview

References

• WHO. Immunization safety surveillance: guidelines for immunization programme managers on surveillance of adverse events following immunization. 3rd ed. Manila: World Health Organization; Pacific: Regional Office for the Western; 2016.
   Google Scholar
• Healy CM, Rench MA, Baker CJ. Importance of timing of maternal combined tetanus, diphtheria, and acellular pertussis (Tdap) immunization and protection of young infants. Clin Infect Dis. 2013;56(4):539–544.
   PubMed Web of Science ®Google Scholar
• CDC. Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine (Tdap) in pregnant women and persons who have or anticipate having close contact with an infant aged <12 months – Advisory Committee on Immunization Practices (ACIP), 2011. MMWR Morb Mortal Wkly Rep. 2011;60(41):1424–1426.
   PubMedGoogle Scholar
• CDC. Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap) in pregnant wome. MMWR Morb Mortal Wkly Rep. 2013;62(7):131–135.
   PubMed Web of Science ®Google Scholar
• Conferenza Stato-Regioni. Schema di intesa tra il Governo, le Regioni e le Province autonome di Trento e di Bolzano sul documento recante Piano nazionale della prevenzione vaccinale 2017–2019; 19 gennaio 2017 [cited 2019 June 22]. Available from: http://archivio.statoregioni.it/dettaglioDoc50a5.html?idprov=18027&iddoc=56289&tipodoc=5&CONF=CSR.
   Google Scholar
• Maurici M, Dugo V, Zaratti L, et al. Knowledge and attitude of pregnant women toward flu vaccination: a cross-sectional survey. J Matern Fetal Neonatal Med. 2016;29(19):3147–3150.
   PubMed Web of Science ®Google Scholar
• Napolitano F, Napolitano P, Angelillo IF. Seasonal influenza vaccination in pregnant women: knowledge, attitudes, and behaviors in Italy. BMC Infect Dis. 2017;17(1):48.
   PubMed Web of Science ®Google Scholar
• Prospero E, Galmozzi S, Paris V, et al. Factors influencing refusing of flu vaccination among pregnant women in Italy: healthcare workers’ role. Influenza Other Respi Viruses.. 2019;13(2):201–207.
   PubMed Web of Science ®Google Scholar
• Galmozzi S, Zocco G, D’Alleva A, et al. Vaccinazione antinfluenzale in gravidanza: uno studio pilota nelle Marche. Not Ist Super Sanità. 2018;31(11):Inserto BEN:1–6.
   Google Scholar
• Rizzo C, Canessa C, Chini L, et al. Le vaccinazioni in gravidanza: uno strumento fondamentale per la prevenzione dell’influenza e della pertosse nelle mamme e nei neonati Milan, IT: società Italiana di Allergologia e Immunologia Pediatrica (SIAIP); 2018 June 26 [cited 2019 August 2]. Available from: https://www.siaip.it/site/search/gravidanza.
   Google Scholar
• Ricco’ M, Vezzosi L, Gualerzi G, et al. Knowledge, attitudes, beliefs and practices of obstetrics-gynecologists on seasonal influenza and pertussis immunizations in pregnant women: preliminary results from North-Western Italy. Minerva Ginecol. 2019;71(4):288–297.
   PubMed Web of Science ®Google Scholar
• Cousens S, Blencowe H, Stanton C, et al. National, regional, and worldwide estimates of stillbirth rates in 2009 with trends since 1995: a systematic analysis. Lancet. 2011;377(9774):1319–1330.
   PubMed Web of Science ®Google Scholar
• WHO. Interim report to WHO initiative for vaccine research. WHO Taskforce to evaluate influenza data to inform vaccine impact and economic modelling. 24 March 2015. World Health Organization; 2019 [cited 2019 June 12]. Available from: https://www.who.int/immunization/sage/meetings/2015/april/1_Interim_Report_WHO_Initiative_Vaccine_Research_24March_2015_execSAGE.pdf
   Google Scholar
• Zaman K, Roy E, Arifeen SE, et al. Effectiveness of maternal influenza immunization in mothers and infants. N Engl J Med. 2008;359(15):1555–1564.
   PubMed Web of Science ®Google Scholar
• Tapia MD, Sow SO, Tamboura B, et al. Maternal immunisation with trivalent inactivated influenza vaccine for prevention of influenza in infants in Mali: a prospective, active-controlled, observer-blind, randomised phase 4 trial. Lancet Infect Dis. 2016;16(9):1026–1035.
   PubMed Web of Science ®Google Scholar
• Baethge C, Goldbeck-Wood S, Mertens S. SANRA-a scale for the quality assessment of narrative review articles. Res Integr Peer Rev. 2019;4(1):5.
   PubMedGoogle Scholar
• Gasparyan AY, Ayvazyan L, Blackmore H, et al. Writing a narrative biomedical review: considerations for authors, peer reviewers, and editors. Rheumatol Int. 2011;31(11):1409–1417.
   PubMed Web of Science ®Google Scholar
• Pautasso M. Ten simple rules for writing a literature review. PLOS Comput Biol. 2013;9(7):e1003149.
   PubMed Web of Science ®Google Scholar
• Byrne JA. Improving the peer review of narrative literature reviews. Res Integr Peer Rev. 2016;1(1):12.
   PubMedGoogle Scholar
• WHO. Tetanus vaccines: WHO position paper – February 2017. Wkly Epidemiol Rec. 2017;92(6):53–76.
   PubMedGoogle Scholar
• WHO. Tetanus. immunization, vaccines and biologicals: World Health Organization; 2019 [updated 2019 July 25; cited 2019 July 31]. Available from: https://www.who.int/immunization/monitoring_surveillance/burden/vpd/surveillance_type/passive/tetanus/en/.
   Google Scholar
• ECDC. Tetanus. In: Annual epidemiological report for 2017. Stockholm: European Centre for Disease Prevention and Control (ECDC); 2019 [cited 2019 July 12]. Available from: https://www.ecdc.europa.eu/sites/portal/files/documents/tetanus-annual-epidemiological-report-2017_0.pdf
   Google Scholar
• Filia A, Bella A, von Hunolstein C, et al. Tetanus in Italy 2001–2010: a continuing threat in older adults. Vaccine. 2014;32(6):639–644.
   PubMed Web of Science ®Google Scholar
• WHO, UNICEF, World Health Organization and United Nations Children’s Fund; Ensuring sustained protection against diphtheria: replacing TT with Td vaccine. 12th version. WHO/UNICEF Guidance Note; 2019 [cited 2019 July 23]. Available from: https://www.unicef.org/health/files/Guide_to_TT_to_Td_Replacement_Final_12.09.2018.pdf.
   Google Scholar
• Tiwari TS, Golaz A, Yu DT, et al. Investigations of 2 cases of diphtheria-like illness due to toxigenic Corynebacterium ulcerans. Clin Infect Dis. 2008;46(3):395–401.
   PubMed Web of Science ®Google Scholar
• WHO. Diphtheria. immunization, vaccines and biologicals: World Health Organization; 2019 [updated 2019 July 25; cited 2019 July 31]. Available from: https://www.who.int/immunization/monitoring_surveillance/burden/vpd/surveillance_type/passive/diphtheria/en/.
   Google Scholar
• ECDC. Diphtheria. Annual epidemiological report for 2017; 2019 [cited 2019 July 31]. Available from: https://ecdc.europa.eu/sites/portal/files/documents/diphtheria-annual-epidemiological-report-2017.pdf.
   Google Scholar
• Difterite. La nostra salute. Ministero della Salute; 2019 [updated 2019 March 25; cited 2019 August 14. Available from: http://www.salute.gov.it/portale/salute/p1_5.jsp?id=2&area=Malattie_infettive.
   Google Scholar
• CDC. Pertussis (whooping cough). Surveillance and reporting trends. Centers for Disease Control and Prevention; 2019 [cited 2019 June 12]. Available from: https://www.cdc.gov/pertussis/surv-reporting.html.
   Google Scholar
• Wendelboe AM, Njamkepo E, Bourillon A, et al. Transmission of Bordetella pertussis to young infants. Pediatr Infect Dis J. 2007;26(4):293–299.
   PubMed Web of Science ®Google Scholar
• Skoff TH, Kenyon C, Cocoros N, et al. Sources of infant pertussis infection in the United States. Pediatrics. 2015;136(4):635–641.
   PubMed Web of Science ®Google Scholar
• Bertilone C, Wallace T, Selvey LA. Finding the “who” in whooping cough: vaccinated siblings are important pertussis sources in infants 6 months of age and under. Commun Dis Intell Q Rep. 2014;38(3):E195–E200.
   PubMedGoogle Scholar
• WHO. Pertussis. Immunization, vaccines and biologicals: World Health Organization; 2019 [updated 2019 July 25; cited 2019 July 31]. Available from: https://www.who.int/immunization/monitoring_surveillance/burden/vpd/surveillance_type/passive/pertussis/en/.
   Google Scholar
• ECDC. Pertussis. Stockholm: European Centre for Disease Prevention and Control. Annual epidemiological report for 2017; 2019 [Cited 2019 July 31]. Available from: https://ecdc.europa.eu/sites/portal/files/documents/AER_for_2017-pertussis.pdf.
   Google Scholar
• Vitek CR, Pascual FB, Baughman AL, et al. Increase in deaths from pertussis among young infants in the United States in the 1990s. Pediatr Infect Dis J. 2003;22(7):628–634.
   PubMed Web of Science ®Google Scholar
• Winter K, Harriman K, Zipprich J, et al. California pertussis epidemic, 2010. J Pediatr. 2012;161(6):1091–1096.
   PubMed Web of Science ®Google Scholar
• CDC. Pertussis epidemic-Washington. MMWR Morb Mortal Wkly Rep. 2012;61(28):517–522.
   PubMedGoogle Scholar
• Hanson MP, Kwan-Gett TS, Baer A, et al. Infant pertussis epidemiology and implications for tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccination: King County, Washington, 2002 through 2007. Arch Pediatr Adolesc Med. 2011;165(7):647–652.
   PubMedGoogle Scholar
• Wortis N, Strebel PM, Wharton M, et al. Pertussis deaths: report of 23 cases in the United States, 1992 and 1993. Pediatrics. 1996;97(5):607–612.
   PubMed Web of Science ®Google Scholar
• CDC. Clinical complications. Pertussis (whooping cough): Centers for Disease Control and Prevention; 2019 [updated 2017 August 7; cited 2019 July 13]. Available from: https://www.cdc.gov/pertussis/clinical/complications.html.
   Google Scholar
• Blake N, Stevenson K, England D. H1N1 pandemic: life span considerations. AACN Adv Crit Care. 2009;20(4):334–341.
   PubMedGoogle Scholar
• CDC. Novel influenza A (H1N1) virus infections in three pregnant women – United States, April–May 2009. MMWR Morb Mortal Wkly Rep. 2009;58(18):497–500.
   PubMedGoogle Scholar
• Chan M. Statements 2009. World now at the start of 2009 influenza pandemic. World Health Organization; 2009 [cited 2019 July 13]. Available from: https://www.who.int/mediacentre/news/statements/2009/h1n1_pandemic_phase6_20090611/en/.
   Google Scholar
• Chavant F, Ingrand I, Jonville-Bera AP, et al. The PREGVAXGRIP study: a cohort study to assess foetal and neonatal consequences of in utero exposure to vaccination against A(H1N1)v2009 influenza. Drug Saf. 2013;36(6):455–465.
   PubMed Web of Science ®Google Scholar
• Dodds L, McNeil SA, Fell DB, et al. Impact of influenza exposure on rates of hospital admissions and physician visits because of respiratory illness among pregnant women. CMAJ. 2007;176(4):463–468.
   PubMed Web of Science ®Google Scholar
• Kraus TA, Engel SM, Sperling RS, et al. Characterizing the pregnancy immune phenotype: results of the viral immunity and pregnancy (VIP) study. J Clin Immunol. 2012;32(2):300–311.
   PubMed Web of Science ®Google Scholar
• Trushakova S, Kisteneva L, Guglieri-López B, et al. Epidemiology of influenza in pregnant women hospitalized with respiratory illness in Moscow, 2012/2013–2015/2016: a hospital-based active surveillance study. BMC Preg Childbirth. 2019;19(1):72.
   PubMed Web of Science ®Google Scholar
• Mertz D, Geraci J, Winkup J, et al. Pregnancy as a risk factor for severe outcomes from influenza virus infection: a systematic review and meta-analysis of observational studies. Vaccine. 2017;35(4):521–528.
   PubMed Web of Science ®Google Scholar
• Jamieson DJ, Honein MA, Rasmussen SA, et al. H1N1 2009 influenza virus infection during pregnancy in the USA. Lancet. 2009;374(9688):451–458.
   PubMed Web of Science ®Google Scholar
• Van Kerkhove MD, Vandemaele KA, Shinde V, et al. Risk factors for severe outcomes following 2009 influenza A (H1N1) infection: a global pooled analysis. PLoS Med. 2011;8(7):e1001053.
   PubMed Web of Science ®Google Scholar
• Puig-Barberà J, Mira-Iglesias A, Burtseva E, et al. Influenza epidemiology and influenza vaccine effectiveness during the 2015–2016 season: results from the Global Influenza Hospital Surveillance Network. BMC Infect Dis. 2019;19(1):415.
   PubMed Web of Science ®Google Scholar
• Jit M, Cromer D, Baguelin M, et al. The cost-effectiveness of vaccinating pregnant women against seasonal influenza in England and Wales. Vaccine. 2010;29(1):115–122.
   PubMed Web of Science ®Google Scholar
• Merk H, Nylén G, Kühlmann-Berenzon S, et al. Number needed to vaccinate to prevent hospitalizations of pregnant women due to inter-pandemic influenza in Sweden, 2003–2009. Vaccine. 2014;32(52):7135–7140.
   PubMed Web of Science ®Google Scholar
• Callaghan WM, Chu SY, Jamieson DJ. Deaths from seasonal influenza among pregnant women in the United States, 1998–2005. Obstet Gynecol. 2010;115(5):919–923.
   PubMed Web of Science ®Google Scholar
• Pierce M, Kurinczuk JJ, Spark P, et al. Perinatal outcomes after maternal 2009/H1N1 infection: national cohort study. BMJ. 2011;342(jun14 2):d3214.
   PubMed Web of Science ®Google Scholar
• Poehling KA, Edwards KM, Weinberg GA, et al. The underrecognized burden of influenza in young children. N Engl J Med. 2006;355(1):31–40.
   PubMed Web of Science ®Google Scholar
• Poehling KA, Edwards KM, Griffin MR, et al. The burden of influenza in young children, 2004–2009. Pediatrics. 2013;131(2):207–216.
   PubMed Web of Science ®Google Scholar
• Fell DB, Buckeridge DL, Platt RW, et al. Circulating influenza virus and adverse pregnancy outcomes: a time-series study. Am J Epidemiol. 2016;184(3):163–175.
   PubMed Web of Science ®Google Scholar
• Conferenza Stato-Regioni. Schema di intesa tra il Governo, le Regioni e le Provincie autonome di Trento e di Bolzano sul documento recante Piano nazionale per l’eliminazione del morbillo e della rosolia congenita (PNEMoRC); 2010–2015; 2011 [cited 2019 June 22]. Available from: http://archivio.statoregioni.it/DettaglioDoc5d95.html?IDDoc=31044&IdProv=9309&tipodoc=2&CONF=CSR.
   Google Scholar
• Ministero della Salute. Bozza di intesa sul documento recante Piano nazionale per l’eliminazione del morbillo e della rosolia congenita (PNEMoRC) 2019–2023; febbraio 2019; 2019 [cited 2019 July 5]. Available from: https://www.sanita24.ilsole24ore.com/pdf2010/Editrice/ILSOLE24ORE/QUOTIDIANO_SANITA/Online/_Oggetti_Correlati/Documenti/2019/03/07/Morbillo_piano.pdf?uuid=AB9LEGbB.
   Google Scholar
• McLean HQ, Fiebelkorn AP, Temte JL, et al. Prevention of measles, rubella, congenital rubella syndrome, and mumps, 2013: summary recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2013;62(RR–4):1–34.
   Google Scholar
• Marin M, Güris D, Chaves SS, et al. Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2007;56(RR-4):1–40.
   PubMedGoogle Scholar
• Delle Aziende P. Sanitarie per la Salute in Italia: la sorveglianza Passi. Istituto Superiore di Sanità. Epicentro. Centro nazionale per la prevenzione delle malattie e la promozione della salute. [Internet]; 2019 [cited 2019 May 27]. Available from: https://www.epicentro.iss.it/passi/.
   Google Scholar
• Fabiani M, Ferrante G, Minardi V, et al. Comparison of rubella immunization rates in immigrant and Italian women of childbearing age: results from the Italian behavioral surveillance system PASSI (2011–2015). PLoS One. 2017;12(10):e0178122.
   PubMed Web of Science ®Google Scholar
• Facciolà A, Squeri R, Genovese C, et al. Perception of rubella risk in pregnancy: an epidemiological survey on a sample of pregnant women. Ann Ig. 2019;31(2 Supple 1):65–71.
   PubMed Web of Science ®Google Scholar
• Calimeri S, Capua A, La Fauci V, et al. Prevalence of serum anti-rubella virus antibodies among pregnant women in southern Italy. Int J Gynecol Obstet. 2012;116(3):211–213.
   PubMed Web of Science ®Google Scholar
• Grimaldi-Bensouda L, Aubrun E, Leighton P, et al. Agreement between patients’ self-report and medical records for vaccination: the PGRx database. Pharmacoepidemiol Drug Saf. 2013;22(3):278–285.
   PubMed Web of Science ®Google Scholar
• Jiménez-García R, Hernandez-Barrera V, Rodríguez-Rieiro C, et al. Comparison of self-report influenza vaccination coverage with data from a population based computerized vaccination registry and factors associated with discordance. Vaccine. 2014;32(35):4386–4392.
   PubMed Web of Science ®Google Scholar
• Mazzoni S, Brewer S, Durfee J, et al. Patient perspectives of obstetrician-gynecologists as primary care providers. J Reprod Med. 2017;62(1–2):3–8.
   PubMed Web of Science ®Google Scholar
• CDC. Standards for adult immunization practice. Adult Vaccination Resources. Centers for Disease Control and Prevention; 2016 [cited 2019 July 22]. Available from: https://www.cdc.gov/vaccines/hcp/adults/for-practice/standards/index.html
   Google Scholar
• O’Leary ST, Riley LE, Lindley MC, et al. Vaccination practices among obstetrician/gynecologists for non-pregnant patients. Am J Prev Med. 2019;56(3):429–436.
   PubMed Web of Science ®Google Scholar
• Committee on Obstetric Practice. ACOG Committee Opinion No. 521: update on immunization and pregnancy: tetanus, diphtheria, and pertussis vaccination. Obstet Gynecol. 2012;119(3):690–691.
   PubMedGoogle Scholar
• Davies SC. Temporary programme of pertussis (whooping cough) vaccination of pregnant women. London: Department of Health; 2012 [cited 2019 August 1]. Available from: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/212947/CMO-Pertussis-27-09-2012-FINAL.pdf.
   Google Scholar
• Banca dati farmaci. Agenzia Italiana del Farmaco [Internet]; 2019 [cited 2019 August 1]. Available from: https://farmaci.agenziafarmaco.gov.it/bancadatifarmaci/home.
   Google Scholar
• Liang JL, Tiwari T, Moro P, et al. Prevention of pertussis, tetanus, and diphtheria with vaccines in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2018;67(2):1–44.
   PubMed Web of Science ®Google Scholar
• SIGO, SIMP, AOGOI, et al. Vaccinazioni in gravidanza. Proteggila per proteggerli; 2019 [cited 2019 May 20]. Available from: https://www.sigo.it/news/vaccinazioni-in-gravidanza-proteggila-per-proteggerli/.
   Google Scholar
• Public Health England. Pertussis: the green Book. Immunisation against infectious disease. London, United Kingdom: Public Health England; 2016 [cited 2019 June 3]. Available from: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/514363/Pertussis_Green_Book_Chapter_24_Ap2016.pdf.
   Google Scholar
• JCVI. Minute of the meeting on 3 February 2016. Oxford: Joint Committee on Vaccination and Immunisation; 2019 [cited 2019 June 3]. Available from: http://www.nitag-resource.org/uploads/media/default/0001/03/5c7ce952ec60f9f20ae4d307822b1de6d9ae3d57.pdf.
   Google Scholar
• Eberhardt CS, Blanchard-Rohner G, Lemaître B, et al. Maternal immunization earlier in pregnancy maximizes antibody transfer and expected infant seropositivity against pertussis. Clin Infect Dis. 2016;62(7):829–836.
   PubMed Web of Science ®Google Scholar
• Broder KR, Cortese MM, Iskander JK, et al. Preventing tetanus, diphtheria, and pertussis among adolescents: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2006;55(RR-3):1–34.
   PubMedGoogle Scholar
• Kretsinger K, Broder KR, Cortese MM, et al. Preventing tetanus, diphtheria, and pertussis among adults: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine recommendations of the Advisory Committee on Immunization Practices (ACIP) and recommendation of ACIP, supported by the Healthcare Infection Control Practices Advisory Committee (HICPAC), for use of Tdap among health-care personnel. MMWR Recomm Rep. 2006;55(RR-17):1–37.
   Google Scholar
• Ordinanza del vice Ministro del lavoro, della Salute e delle Politiche Sociali 30 settembre 2009, recante Misure urgenti in materia di protezione dal virus influenzale A(H1N1). G.U. Serie Generale, n. 234 del 08 ottobre 2009 [cited 2019 July 29]. Available from: http://www.trovanorme.salute.gov.it/norme/dettaglioAtto?completo=si&id=30406
   Google Scholar
• WHO. Background paper on influenza vaccines and immunization. SAGE Working Group: World Health Organization; 2012 [cited 2019 May 21]. Available from: https://www.who.int/influenza/vaccines/SAGE_information/en/.
   Google Scholar
• WHO. Vaccines against influenza WHO position paper – November 2012. Wkly Epidemiol Rec. 2012;87(47):461–476.
   PubMedGoogle Scholar
• ECDC. Seasonal influenza vaccination in Europe. Vaccination recommendations and coverage rates in the EU Member States for eight influenza seasons 2007–2008 to 2014–2015. Stockholm: European Centre for Disease Prevention and Control; 2017 [cited 2019 May 30]. Available from: https://ecdc.europa.eu/en/publications-data/seasonal-influenza-vaccination-europe-vaccination-recommendations-and-coverage-2007–2015.
   Google Scholar
• NHS. The national flu immunisation programme 2018/192018; 2019 [cited 2019 July 4]. Available from: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/694779/Annual_national_flu_programme_2018-2019.pdf.
   Google Scholar
• Tamma PD, Ault KA, del Rio C, et al. Safety of influenza vaccination during pregnancy. Am J Obstet Gynecol. 2009;201(6):547–552.
   PubMed Web of Science ®Google Scholar
• Fiore AE, Uyeki TM, Broder K, et al. Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. MMWR Recomm Rep. 2010;59(RR–8):1–62.
   PubMedGoogle Scholar
• Grohskopf LA, Sokolow LZ, Olsen SJ, et al. Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices, United States, 2015–16 influenza season. MMWR Morb Mortal Wkly Rep. 2015;64(30):818–825.
   PubMed Web of Science ®Google Scholar
• de Greeff SC, Mooi FR, Westerhof A, et al. Pertussis disease burden in the household: how to protect young infants. Clin Infect Dis. 2010;50(10):1339–1345.
   PubMed Web of Science ®Google Scholar
• Amirthalingam G, Andrews N, Campbell H, et al. Effectiveness of maternal pertussis vaccination in England: an observational study. Lancet. 2014;384(9953):1521–1528.
   PubMed Web of Science ®Google Scholar
• Quinello C, Quintilio W, Carneiro-Sampaio M, et al. Passive acquisition of protective antibodies reactive with Bordetella pertussis in newborns via placental transfer and breast-feeding. Scand J Immunol. 2010;72(1):66–73.
   PubMed Web of Science ®Google Scholar
• van den Berg JP, Westerbeek EA, Berbers GA, et al. Transplacental transport of IgG antibodies specific for pertussis, diphtheria, tetanus, haemophilus influenzae type b, and Neisseria meningitidis serogroup C is lower in preterm compared with term infants. Pediatr Infect Dis J. 2010;29(9):801–805.
   PubMed Web of Science ®Google Scholar
• Ercan TE, Sonmez C, Vural M, et al. Seroprevalance of pertussis antibodies in maternal and cord blood of preterm and term infants. Vaccine. 2013;31(38):4172–4176.
   PubMed Web of Science ®Google Scholar
• Abu Raya B, Srugo I, Kessel A, et al. The induction of breast milk pertussis specific antibodies following gestational tetanus-diphtheria-acellular pertussis vaccination. Vaccine. 2014;32(43):5632–5637.
   PubMed Web of Science ®Google Scholar
• De Schutter S, Maertens K, Baerts L, et al. Quantification of vaccine-induced antipertussis toxin secretory IgA antibodies in breast milk: comparison of different vaccination strategies in women. Pediatr Infect Dis J. 2015;34(6):e149–e152.
   PubMed Web of Science ®Google Scholar
• Malek A, Sager R, Kuhn P, et al. Evolution of maternofetal transport of immunoglobulins during human pregnancy. Am J Reprod Immunol. 1996;36(5):248–255.
   PubMed Web of Science ®Google Scholar
• Lima L, Molina M, Pereira BS, et al. Acquisition of specific antibodies and their influence on cell-mediated immune response in neonatal cord blood after maternal pertussis vaccination during pregnancy. Vaccine. 2019;37(19):2569–2579.
   PubMed Web of Science ®Google Scholar
• Rice TF, Diavatopoulos DA, Smits GP, et al. Antibody responses to Bordetella pertussis and other childhood vaccines in infants born to mothers who received pertussis vaccine in pregnancy – a prospective, observational cohort study from the United Kingdom. Clin Exp Immunol. 2019;197(1):1–10.
   PubMed Web of Science ®Google Scholar
• Nunes MC, Cutland CL, Dighero B, et al. Kinetics of hemagglutination-inhibiting antibodies following maternal influenza vaccination among mothers with and those without HIV infection and their infants. J Infect Dis. 2015;212(12):1976–1987.
   PubMed Web of Science ®Google Scholar
• Schlaudecker EP, Steinhoff MC, Omer SB, et al. IgA and neutralizing antibodies to influenza A virus in human milk: a randomized trial of antenatal influenza immunization. PLoS One. 2013;8(8):e70867.
   PubMed Web of Science ®Google Scholar
• Maltezou HC, Fotiou A, Antonakopoulos N, et al. Impact of postpartum influenza vaccination of mothers and household contacts in preventing febrile episodes, influenza-like illness, healthcare seeking, and administration of antibiotics in young infants during the 2012–2013 influenza season. Clin Infect Dis. 2013;57(11):1520–1526.
   PubMed Web of Science ®Google Scholar
• Järvinen KM, Wang J, Seppo AE, et al. Novel multiplex assay for profiling influenza antibodies in breast milk and serum of mother–infant pairs. F1000Res. 2018;7:1822.
   PubMedGoogle Scholar
• Steinhoff MC, Omer SB, Roy E, et al. Influenza immunization in pregnancy – antibody responses in mothers and infants. N Engl J Med. 2010;362(17):1644–1646.
   PubMed Web of Science ®Google Scholar
• Jackson LA, Patel SM, Swamy GK, et al. Immunogenicity of an inactivated monovalent 2009 H1N1 influenza vaccine in pregnant women. J Infect Dis. 2011;204(6):854–863.
   PubMed Web of Science ®Google Scholar
• WHO. Diphtheria vaccine: WHO position paper – August 2017. Wkly Epidemiol Rec. 2017;92(31):417–435.
   PubMedGoogle Scholar
• Boyd JS. Tetanus in the African and European theatres of war, 1939–1945. Lancet. 1946;1(6387):113–119.
   PubMed Web of Science ®Google Scholar
• Long AP. Tetanus toxoid, its use in the United States Army. Am J Public Health Nations Health. 1943;33(1):53–57.
   PubMedGoogle Scholar
• Rahman M, Chen LC, Chakraborty J, et al. Use of tetanus toxoid for the prevention of neonatal tetanus. 1. Reduction of neonatal mortality by immunization of non-pregnant and pregnant women in rural Bangladesh. Bull World Health Organ. 1982;60(2):261–267.
   PubMed Web of Science ®Google Scholar
• Hardegree MC, Barile MF, Pittman M, et al. Immunization against neonatal tetanus in New Guinea. Bull World Health Organ. 1970;43(3):439–451.
   PubMedGoogle Scholar
• Newell KW, Dueñas Lehmann A, LeBlanc DR, et al. The use of toxoid for the prevention of tetanus neonatorum. Final report of a double-blind controlled field trial. Bull World Health Organ. 1966;35(6):863–871.
   PubMed Web of Science ®Google Scholar
• WHO. Protecting all against tetanus. Guide to sustaining maternal and neonatal tetanus elimination (MNTE) and broadening tetanus protection for all populations. Geneva: World Health Organization; 2019 [cited 2019 July 19]. Available from: https://www.who.int/immunization/diseases/tetanus/Protecting_All_Against_Tetanus_final_draftV4_23Jan_web.pdf?ua=1.
   Google Scholar
• CDC. Diphtheria, tetanus, and pertussis: recommendations for vaccine use and other preventive measures. Recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR Recomm Rep. 1991;40(RR–10):1–28.
   Google Scholar
• Carcione D, Regan AK, Tracey L, et al. The impact of parental postpartum pertussis vaccination on infection in infants: a population-based study of cocooning in Western Australia. Vaccine. 2015;33(42):5654–5661.
   PubMed Web of Science ®Google Scholar
• Quinn HE, Snelling TL, Habig A, et al. Parental Tdap boosters and infant pertussis: a case-control study. Pediatrics. 2014;134(4):713–720.
   PubMed Web of Science ®Google Scholar
• Westra TA, de Vries R, Tamminga JJ, et al. Cost-effectiveness analysis of various pertussis vaccination strategies primarily aimed at protecting infants in the Netherlands. Clin Ther. 2010;32(8):1479–1495.
   PubMed Web of Science ®Google Scholar
• Blain AE, Lewis M, Banerjee E, et al. An assessment of the cocooning strategy for preventing infant pertussis-United States, 2011. Clin Infect Dis. 2016;63(Suppl 4):S221–S226.
   PubMed Web of Science ®Google Scholar
• WHO. Pertussis vaccines: WHO position paper, August 2015 – recommendations. Vaccine. 2016;34(12):1423–1425.
   PubMed Web of Science ®Google Scholar
• Meng QH, Luo J, Yang F, et al. A general lack of IgG against pertussis toxin in Chinese pregnant women and newborns. Pediatr Infect Dis J. 2018;37(9):934–938.
   PubMed Web of Science ®Google Scholar
• Furuta M, Sin J, Ng ESW, et al. Efficacy and safety of pertussis vaccination for pregnant women – a systematic review of randomised controlled trials and observational studies. BMC Preg Childbirth. 2017;17(1):390.
   PubMed Web of Science ®Google Scholar
• Healy CM, Rench MA, Swaim LS, et al. Association between third-trimester Tdap immunization and neonatal pertussis antibody concentration. JAMA. 2018;320(14):1464–1470.
   PubMed Web of Science ®Google Scholar
• Gall SA, Myers J, Pichichero M. Maternal immunization with tetanus-diphtheria-pertussis vaccine: effect on maternal and neonatal serum antibody levels. Am J Obstet Gynecol. 2011;204(4):334.e1–334.e5.
   Web of Science ®Google Scholar
• Hardy-Fairbanks AJ, Pan SJ, Decker MD, et al. Immune responses in infants whose mothers received Tdap vaccine during pregnancy. Pediatr Infect Dis J. 2013;32(11):1257–1260.
   PubMed Web of Science ®Google Scholar
• Fallo AA, Neyro SE, Manonelles GV, et al. Prevalence of pertussis antibodies in maternal blood, cord serum, and infants from mothers with and those without Tdap booster vaccination during pregnancy in Argentina. J Pediatr Infect Dis Soc. 2018;7(1):11–17.
   PubMed Web of Science ®Google Scholar
• Libster R, Edwards KM. How can we best prevent pertussis in infants? Clin Infect Dis. 2012;54(1):85–87.
   PubMed Web of Science ®Google Scholar
• Van Rie A, Wendelboe AM, Englund JA. Role of maternal pertussis antibodies in infants. Pediatr Infect Dis J. 2005;24(Supplement):S62–S65.
   PubMedGoogle Scholar
• Orenstein WA, Bernier RH, Dondero TJ, et al. Field evaluation of vaccine efficacy. Bull World Health Organ. 1985;63(6):1055–1068.
   PubMed Web of Science ®Google Scholar
• Saul N, Wang K, Bag S, et al. Effectiveness of maternal pertussis vaccination in preventing infection and disease in infants: the NSW Public Health Network case-control study. Vaccine. 2018;36(14):1887–1892.
   PubMed Web of Science ®Google Scholar
• Skoff TH, Blain AE, Watt J, et al. Impact of the US maternal tetanus, diphtheria, and acellular pertussis vaccination program on preventing pertussis in infants <2 months of age: a case-control evaluation. Clin Infect Dis. 2017;65(12):1977–1983.
   PubMed Web of Science ®Google Scholar
• Dabrera G, Amirthalingam G, Andrews N, et al. A case-control study to estimate the effectiveness of maternal pertussis vaccination in protecting newborn infants in England and Wales, 2012–2013. Clin Infect Dis. 2015;60(3):333–337.
   PubMed Web of Science ®Google Scholar
• Bellido-Blasco J, Guiral-Rodrigo S, Míguez-Santiyán A, et al. A case-control study to assess the effectiveness of pertussis vaccination during pregnancy on newborns, Valencian community, Spain, 1 March 2015 to 29 February 2016. Euro Surveill. 2017;22(22):pii: 30545.
   Google Scholar
• Amirthalingam G, Campbell H, Ribeiro S, et al. Sustained effectiveness of the maternal pertussis immunization program in England 3 years following introduction. Clin Infect Dis. 2016;63(Suppl 4):S236–S243.
   PubMed Web of Science ®Google Scholar
• Winter K, Cherry JD, Harriman K. Effectiveness of prenatal tetanus, diphtheria, and acellular pertussis vaccination on pertussis severity in infants. Clin Infect Dis. 2017;64(1):9–14.
   PubMed Web of Science ®Google Scholar
• Baxter R, Bartlett J, Fireman B, et al. Effectiveness of vaccination during pregnancy to prevent infant pertussis. Pediatrics. 2017;139(5):e20164091.
   PubMed Web of Science ®Google Scholar
• Becker-Dreps S, Butler AM, McGrath LJ, et al. Effectiveness of prenatal tetanus, diphtheria, acellular pertussis vaccination in the prevention of infant pertussis in the U.S. Am J Prev Med. 2018;55(2):159–166.
   PubMed Web of Science ®Google Scholar
• Cody CL, Baraff LJ, Cherry JD, et al. Nature and rates of adverse reactions associated with DTP and DT immunizations in infants and children. Pediatrics. 1981;68(5):650–660.
   PubMed Web of Science ®Google Scholar
• Baraff LJ, Cherry JD, Cody CL, et al. DTP vaccine reactions: effect of prior reactions on rate of subsequent reactions. Dev Biol Stand. 1985;61:423–428.
   PubMedGoogle Scholar
• Blumberg DA, Lewis K, Mink CM, et al. Severe reactions associated with diphtheria-tetanus-pertussis vaccine: detailed study of children with seizures, hypotonic-hyporesponsive episodes, high fevers, and persistent crying. Pediatrics. 1993;91(6):1158–1165.
   PubMed Web of Science ®Google Scholar
• Liang J, Tiwari T, Moro P, et al. Summary of vaccine safety studies of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine (Tdap) in pregnant women and their infants: supplementary table for: prevention of pertussis, tetanus, and diphtheria with vaccines in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP). Centers for Disease Control and Prevention; 2018 [updated 2018 April 27; cited 2019 August 21]. Available from: https://stacks.cdc.gov/view/cdc/52820.
   Google Scholar
• Munoz FM, Bond NH, Maccato M, et al. Safety and immunogenicity of tetanus diphtheria and acellular pertussis (Tdap) immunization during pregnancy in mothers and infants: a randomized clinical trial. JAMA. 2014;311(17):1760–1769.
   PubMed Web of Science ®Google Scholar
• Villarreal Pérez JZ, Ramírez Aranda JM, de la O Cavazos M, et al. Randomized clinical trial of the safety and immunogenicity of the Tdap vaccine in pregnant Mexican women. Hum Vaccin Immunother. 2017;13(1):128–135.
   PubMed Web of Science ®Google Scholar
• Demicheli V, Barale A, Rivetti A. Vaccines for women for preventing neonatal tetanus. Cochrane Database Syst Rev. 2015;7(7):CD002959.
   Google Scholar
• Sukumaran L, McCarthy NL, Kharbanda EO, et al. Association of Tdap vaccination with acute events and adverse birth outcomes among pregnant women with prior tetanus-containing immunizations. JAMA. 2015;314(15):1581–1587.
   PubMed Web of Science ®Google Scholar
• Kharbanda EO, Vazquez-Benitez G, Lipkind HS, et al. Evaluation of the association of maternal pertussis vaccination with obstetric events and birth outcomes. JAMA. 2014;312(18):1897–1904.
   PubMed Web of Science ®Google Scholar
• Griffin JB, Yu L, Watson D, et al. Pertussis Immunisation in Pregnancy Safety (PIPS) Study: A retrospective cohort study of safety outcomes in pregnant women vaccinated with Tdap vaccine. Vaccine. 2018;36(34):5173–5179.
   PubMed Web of Science ®Google Scholar
• Morgan JL, Baggari SR, McIntire DD, et al. Pregnancy outcomes after antepartum tetanus, diphtheria, and acellular pertussis vaccination. Obstet Gynecol. 2015;125(6):1433–1438.
   PubMed Web of Science ®Google Scholar
• Walls T, Graham P, Petousis-Harris H, et al. Infant outcomes after exposure to Tdap vaccine in pregnancy: an observational study. BMJ Open. 2016;6(1):e009536.
   PubMed Web of Science ®Google Scholar
• Layton JB, Butler AM, Li D, et al. Prenatal Tdap immunization and risk of maternal and newborn adverse events. Vaccine. 2017;35(33):4072–4078.
   PubMed Web of Science ®Google Scholar
• DeSilva M, Vazquez-Benitez G, Nordin JD, et al. Maternal Tdap vaccination and risk of infant morbidity. Vaccine. 2017;35(29):3655–3660.
   PubMed Web of Science ®Google Scholar
• Datwani H, Moro PL, Harrington T, et al. Chorioamnionitis following vaccination in the vaccine adverse event reporting system. Vaccine. 2015;33(27):3110–3113.
   PubMed Web of Science ®Google Scholar
• Becerra-Culqui TA, Getahun D, Chiu V, et al. Prenatal tetanus, diphtheria, acellular pertussis vaccination and autism spectrum disorder. Pediatrics. 2018;142(3):e20180120.
   PubMed Web of Science ®Google Scholar
• Sukumaran L, McCarthy NL, Kharbanda EO, et al. Infant hospitalizations and mortality after maternal vaccination. Pediatrics. 2018;141(3):e20173310.
   PubMed Web of Science ®Google Scholar
• Ladhani SN, Andrews NJ, Southern J, et al. Antibody responses after primary immunization in infants born to women receiving a pertussis-containing vaccine during pregnancy: single arm observational study with a historical comparator. Clin Infect Dis. 2015;61(11):1637–1644.
   PubMed Web of Science ®Google Scholar
• Wanlapakorn N, Maertens K, Vongpunsawad S, et al. Quantity and quality of antibodies after acellular versus whole cell pertussis vaccines in infants born to mothers who received Tdap during pregnancy: a randomised trial. Clin Infect Dis. 2019;pii: ciz778. doi: 10.1093/cid/ciz778
   Web of Science ®Google Scholar
• Maertens K, Burbidge P, Van Damme P, et al. Pneumococcal immune response in infants whose mothers received tetanus, diphtheria and acellular pertussis vaccination during pregnancy. Pediatr Infect Dis J. 2017;36(12):1186–1192.
   PubMed Web of Science ®Google Scholar
• Hoang HT, Leuridan E, Maertens K, et al. Pertussis vaccination during pregnancy in Vietnam: results of a randomized controlled trial Pertussis vaccination during pregnancy. Vaccine. 2016;34(1):151–159.
   PubMed Web of Science ®Google Scholar
• Maertens K, Hoang TT, Nguyen TD, et al. The effect of maternal pertussis immunization on infant vaccine responses to a booster pertussis-containing vaccine in Vietnam. Clin Infect Dis. 2016;63(Suppl 4):S197–S204.
   PubMed Web of Science ®Google Scholar
• Maertens K, Caboré RN, Huygen K, et al. Pertussis vaccination during pregnancy in Belgium: results of a prospective controlled cohort study. Vaccine. 2016;34(1):142–150.
   PubMed Web of Science ®Google Scholar
• Halperin SA, Langley JM, Ye L, et al. A randomized controlled trial of the safety and immunogenicity of tetanus, diphtheria, and acellular pertussis vaccine immunization during pregnancy and subsequent infant immune response. Clin Infect Dis. 2018;67(7):1063–1071.
   PubMed Web of Science ®Google Scholar
• Zhu Y, van Boemmel-Wegmann S, Albogami Y. Repeat Tdap vaccination and adverse birth outcomes. JAMA. 2016;315(12):1285–1286.
   PubMed Web of Science ®Google Scholar
• Sukumaran L, Omer SB. Repeat Tdap vaccination and adverse birth outcomes – reply. JAMA. 2016;315(12):1286.
   PubMed Web of Science ®Google Scholar
• Sukumaran L, McCarthy NL, Kharbanda EO, et al. Safety of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis and influenza vaccinations in pregnancy. Obstet Gynecol. 2015;126(5):1069–1074.
   PubMed Web of Science ®Google Scholar
• Black S, Nicolay U, Vesikari T, et al. Hemagglutination inhibition antibody titers as a correlate of protection for inactivated influenza vaccines in children. Pediatr Infect Dis J. 2011;30(12):1081–1085.
   PubMed Web of Science ®Google Scholar
• Memoli MJ, Shaw PA, Han A, et al. Evaluation of antihemagglutinin and antineuraminidase antibodies as correlates of protection in an influenza A/H1N1 virus healthy human challenge model. MBio. 2016;7(2):e00417–e00416.
   PubMed Web of Science ®Google Scholar
• Demicheli V, Jefferson T, Ferroni E, et al. Vaccines for preventing influenza in healthy adults. Cochrane Database Syst Rev. 2018;2:CD001269.
   PubMed Web of Science ®Google Scholar
• Madhi SA, Cutland CL, Kuwanda L, et al. Influenza vaccination of pregnant women and protection of their infants. N Engl J Med. 2014;371(10):918–931.
   PubMed Web of Science ®Google Scholar
• Ma F, Zhang L, Jiang R, et al. Prospective cohort study of the safety of an influenza A(H1N1) vaccine in pregnant Chinese women. Clin Vaccine Immunol. 2014;21(9):1282–1287.
   PubMed Web of Science ®Google Scholar
• Eick AA, Uyeki TM, Klimov A, et al. Maternal influenza vaccination and effect on influenza virus infection in young infants. Arch Pediatr Adolesc Med. 2011;165(2):104–111.
   PubMed Web of Science ®Google Scholar
• Yamada T, Yamada T, Morikawa M, et al. Pandemic (H1N1) 2009 in pregnant Japanese women in Hokkaido. J Obstet Gynaecol Res. 2012;38(1):130–136.
   PubMed Web of Science ®Google Scholar
• Steinhoff MC, Katz J, Englund JA, et al. Year-round influenza immunisation during pregnancy in Nepal: a phase 4, randomised, placebo-controlled trial. Lancet Infect Dis. 2017;17(9):981–989.
   PubMed Web of Science ®Google Scholar
• Nunes MC, Cutland CL, Jones S, et al. Efficacy of maternal influenza vaccination against all-cause lower respiratory tract infection hospitalizations in young infants: results from a randomized controlled trial. Clin Infect Dis. 2017;65(7):1066–1071.
   PubMed Web of Science ®Google Scholar
• CDC. Flu vaccination and addressing concerns pregnant women might have about flu vaccine safety. Information and guidance for health care providers. Centers for Disease Control and Prevention; 2019 [cited 2019 July 6]. Available from: https://www.cdc.gov/flu/professionals/vaccination/vaccination-possible-safety-signal.html.
   Google Scholar
• Thompson MG, Kwong JC, Regan AK, et al. Influenza vaccine effectiveness in preventing influenza-associated hospitalizations during pregnancy: a multi-country retrospective test negative design study, 2010–2016. Clin Infect Dis. 2019;68(9):1444–1453.
   PubMed Web of Science ®Google Scholar
• Getahun D, Fassett MJ, Peltier MR, et al. Association between seasonal influenza vaccination with pre- and postnatal outcomes. Vaccine. 2019;37(13):1785–1791.
   PubMed Web of Science ®Google Scholar
• Dabrera G, Zhao H, Andrews N, et al. Effectiveness of seasonal influenza vaccination during pregnancy in preventing influenza infection in infants, England, 2013/14. Euro Surveill. 2014;19(45):20959.
   PubMedGoogle Scholar
• Poehling KA, Szilagyi PG, Staat MA, et al. Impact of maternal immunization on influenza hospitalizations in infants. Am J Obstet Gynecol. 2011;204(6):S141–S148.
   PubMed Web of Science ®Google Scholar
• Regan AK, de Klerk N, Moore HC, et al. Effect of maternal influenza vaccination on hospitalization for respiratory infections in newborns: A retrospective cohort study. Pediatr Infect Dis J. 2016;35(10):1097–1103.
   PubMed Web of Science ®Google Scholar
• Benowitz I, Esposito DB, Gracey KD, et al. Influenza vaccine given to pregnant women reduces hospitalization due to influenza in their infants. Clin Infect Dis. 2010;51(12):1355–1361.
   PubMed Web of Science ®Google Scholar
• Vazquez-Benitez G, Kharbanda EO, Naleway AL, et al. Risk of preterm or small-for-gestational-age birth after influenza vaccination during pregnancy: caveats when conducting retrospective observational studies. Am J Epidemiol. 2016;184(3):176–186.
   PubMed Web of Science ®Google Scholar
• Zerbo O, Modaressi S, Chan B, et al. No association between influenza vaccination during pregnancy and adverse birth outcomes. Vaccine. 2017;35(24):3186–3190.
   PubMed Web of Science ®Google Scholar
• Sheffield JS, Greer LG, Rogers VL, et al. Effect of influenza vaccination in the first trimester of pregnancy. Obstet Gynecol. 2012;120(3):532–537.
   PubMed Web of Science ®Google Scholar
• Giles ML, Krishnaswamy S, Macartney K, et al. The safety of inactivated influenza vaccines in pregnancy for birth outcomes: a systematic review. Hum Vaccin Immunother. 2019;15(3):687–699.
   PubMed Web of Science ®Google Scholar
• Jeong S, Jang EJ, Jo J, et al. Effects of maternal influenza vaccination on adverse birth outcomes: A systematic review and Bayesian meta-analysis. PLoS One. 2019;14(8):e0220910.
   PubMed Web of Science ®Google Scholar
• Nunes MC, Aqil AR, Omer SB, et al. The effects of influenza vaccination during pregnancy on birth outcomes: a systematic review and meta-analysis. Amer J Perinatol. 2016;33(11):1104–1114.
   PubMed Web of Science ®Google Scholar
• Zhang C, Wang X, Liu D, et al. A systematic review and meta-analysis of fetal outcomes following the administration of influenza A/H1N1 vaccination during pregnancy. Int J Gynecol Obstet. 2018;141(2):141–150.
   PubMed Web of Science ®Google Scholar
• Simões EAF, Nunes MC, Carosone-Link P, et al. Trivalent influenza vaccination randomized control trial of pregnant women and adverse fetal outcomes. Vaccine. 2019;37(36):5397–5403.
   PubMed Web of Science ®Google Scholar
• Hutcheon JA, Fell DB, Jackson ML, et al. Detectable risks in studies of the fetal benefits of maternal influenza vaccination. Am J Epidemiol. 2016;184(3):227–232.
   PubMed Web of Science ®Google Scholar
• Hutcheon JA, Savitz DA. Invited commentary: influenza, influenza immunization, and pregnancy-it’s about time. Am J Epidemiol. 2016;184(3):187–191.
   PubMed Web of Science ®Google Scholar
• Savitz DA, Fell DB, Ortiz JR, et al. Does influenza vaccination improve pregnancy outcome? Methodological issues and research needs. Vaccine. 2015;33(47):6430–6435.
   PubMed Web of Science ®Google Scholar
• Adedinsewo DA, Noory L, Bednarczyk RA, et al. Impact of maternal characteristics on the effect of maternal influenza vaccination on fetal outcomes. Vaccine. 2013;31(49):5827–5833.
   PubMed Web of Science ®Google Scholar
• Chambers CD, Johnson D, Xu R, et al. Risks and safety of pandemic H1N1 influenza vaccine in pregnancy: birth defects, spontaneous abortion, preterm delivery, and small for gestational age infants. Vaccine. 2013;31(44):5026–5032.
   PubMed Web of Science ®Google Scholar
• Louik C, Ahrens K, Kerr S, et al. Risks and safety of pandemic H1N1 influenza vaccine in pregnancy: exposure prevalence, preterm delivery, and specific birth defects. Vaccine. 2013;31(44):5033–5040.
   PubMed Web of Science ®Google Scholar
• Louik C, Kerr S, Van Bennekom CM, et al. Safety of the 2011–12, 2012–13, and 2013–14 seasonal influenza vaccines in pregnancy: preterm delivery and specific malformations, a study from the case-control arm of VAMPSS. Vaccine. 2016;34(37):4450–4459.
   PubMed Web of Science ®Google Scholar
• Chambers CD, Johnson DL, Xu R, et al. Safety of the 2010–11, 2011-12, 2012-13, and 2013-14 seasonal influenza vaccines in pregnancy: birth defects, spontaneous abortion, preterm delivery, and small for gestational age infants, a study from the cohort arm of VAMPSS. Vaccine. 2016;34(37):4443–4449.
   PubMed Web of Science ®Google Scholar
• Donahue JG, Kieke BA, King JP, et al. Association of spontaneous abortion with receipt of inactivated influenza vaccine containing H1N1pdm09 in 2010–11 and 2011–12. Vaccine. 2017;35(40):5314–5322.
   PubMed Web of Science ®Google Scholar
• Krubiner CB, Faden RR, Karron RA, et al. Pregnant women and vaccines against emerging epidemic threats: ethics guidance for preparedness, research, and response. Vaccine. 2019;pii: S0264-410X(19)30045-3. doi: 10.1016/j.vaccine.2019.01.011
   Web of Science ®Google Scholar
• Chambers CD, Xu R, Mitchell AA. Commentary on: “Association of spontaneous abortion with receipt of inactivated influenza vaccine containing H1N1pdm09 in 2010–11 and 2011–12”. Vaccine. 2017;35(40):5323–5324.
   PubMed Web of Science ®Google Scholar
• Ault KA, Riley LE. Response to Donahue et al. 2017 in press article. Vaccine. 2018;36(17):2230.
   PubMed Web of Science ®Google Scholar
• Roeca C, Polotsky AJ. Influenza vaccination in early pregnancy. Vaccine. 2018;36(17):2229.
   PubMed Web of Science ®Google Scholar
• Zafar S, Habboush Y, Beidas S. Use of grading of recommendations, assessment, development, and evaluation to combat fake news: a case study of influenza vaccination in pregnancy. JMIR Med Educ. 2018;4(2):e10347.
   PubMedGoogle Scholar
• Brown HL. It is safe to recerive flu shot during pregnancy. The American College of Obstetrician and Gynecologists (ACOG); 2017 [cited 2019 July 8]. Available from: https://www.acog.org/About-ACOG/News-Room/Statements/2017/It-is-Safe-to-Receive-Flu-Shot-During-Pregnancy.
   Google Scholar
• Moro PL, Broder K, Zheteyeva Y, et al. Adverse events in pregnant women following administration of trivalent inactivated influenza vaccine and live attenuated influenza vaccine in the Vaccine Adverse Event Reporting System, 1990–2009. Am J Obstet Gynecol. 2011;204(2):146.e1–146.e7.
   Web of Science ®Google Scholar
• Moro PL, Broder K, Zheteyeva Y, et al. Adverse events following administration to pregnant women of influenza A (H1N1) 2009 monovalent vaccine reported to the Vaccine Adverse Event Reporting System. Am J Obstet Gynecol. 2011;205(5):473.e1–473.e9.
   PubMed Web of Science ®Google Scholar
• Moro P, Baumblatt J, Lewis P, et al. Surveillance of adverse events after seasonal influenza vaccination in pregnant women and their infants in the vaccine Adverse Event Reporting System, July 2010–May 2016. Drug Saf. 2017;40(2):145–152.
   PubMed Web of Science ®Google Scholar
• Munoz FM, Jackson LA, Swamy GK, et al. Safety and immunogenicity of seasonal trivalent inactivated influenza vaccines in pregnant women. Vaccine. 2018;36(52):8054–8061.
   PubMed Web of Science ®Google Scholar
• Conlin AMS, Bukowinski AT, Levine JA, et al. A follow-up comparative safety analysis of pandemic H1N1 vaccination during pregnancy and risk of infant birth defects among U.S. military mothers. Vaccine. 2018;36(20):2855–2860.
   PubMed Web of Science ®Google Scholar
• Kharbanda EO, Vazquez-Benitez G, Romitti PA, et al. First trimester influenza vaccination and risks for major structural birth defects in offspring. J Pediatr. 2017;187:234–239.e4.
   PubMed Web of Science ®Google Scholar
• Olsen SJ, Mirza SA, Vonglokham P, et al. The effect of influenza vaccination on birth outcomes in a cohort of pregnant women in Lao PDR, 2014–2015. Clin Infect Dis. 2016;63(4):487–494.
   PubMed Web of Science ®Google Scholar
• Rolfes MA, Vonglokham P, Khanthamaly V, et al. Measurement of birth outcomes in analyses of the impact of maternal influenza vaccination. Influ Other Respir Viruses. 2019. doi: 10.1111/irv.12673
   PubMed Web of Science ®Google Scholar
• Polyzos KA, Konstantelias AA, Pitsa CE, et al. Maternal influenza vaccination and risk for congenital malformations: A systematic review and meta-analysis. Obstet Gynecol. 2015;126(5):1075–1084.
   PubMed Web of Science ®Google Scholar
• Dauvilliers Y, Arnulf I, Lecendreux M, et al. Increased risk of narcolepsy in children and adults after pandemic H1N1 vaccination in France. Brain. 2013;136(8):2486–2496.
   PubMed Web of Science ®Google Scholar
• Nohynek H, Jokinen J, Partinen M, et al. AS03 adjuvanted AH1N1 vaccine associated with an abrupt increase in the incidence of childhood narcolepsy in Finland. PLoS One. 2012;7(3):e33536.
   PubMed Web of Science ®Google Scholar
• Stowe J, Andrews N, Kosky C, et al. Risk of narcolepsy after AS03 adjuvanted pandemic A/H1N1 2009 influenza vaccine in adults: a case-coverage study in England. Sleep. 2016;39(5):1051–1057.
   PubMed Web of Science ®Google Scholar
• Miller E, Andrews N, Stellitano L, et al. Risk of narcolepsy in children and young people receiving AS03 adjuvanted pandemic A/H1N1 2009 influenza vaccine: retrospective analysis. BMJ. 2013;346(2):f794.
   PubMed Web of Science ®Google Scholar
• Heier MS, Gautvik KM, Wannag E, et al. Incidence of narcolepsy in Norwegian children and adolescents after vaccination against H1N1 influenza A. Sleep Med. 2013;14(9):867–871.
   PubMed Web of Science ®Google Scholar
• O’Flanagan D, Barret AS, Foley M, et al. Investigation of an association between onset of narcolepsy and vaccination with pandemic influenza vaccine, Ireland April 2009–December 2010. Euro Surveill. 2014;19(17):15–25.
   PubMedGoogle Scholar
• Partinen M, Saarenpää-Heikkilä O, Ilveskoski I, et al. Increased incidence and clinical picture of childhood narcolepsy following the 2009 H1N1 pandemic vaccination campaign in Finland. PLoS One. 2012;7(3):e33723.
   PubMed Web of Science ®Google Scholar
• Duffy J, Weintraub E, Vellozzi C, et al. Narcolepsy and influenza A(H1N1) pandemic 2009 vaccination in the United States. Neurology. 2014;83(20):1823–1830.
   PubMed Web of Science ®Google Scholar
• ECDC. Technical report. Narcolepsy in association with pandemic influenza vaccination. A multi-country European epidemiological investigation. Stockholm: European Centre for Disease Prevention and Control; 2012 [cited 2019 July 4]. Available from: https://ecdc.europa.eu/sites/portal/files/media/en/publications/Publications/Vaesco%20report%20FINAL%20with%20cover.pdf.
   Google Scholar
• Trotta F, Da Cas R, Spila Alegiani S, et al. Evaluation of safety of A/H1N1 pandemic vaccination during pregnancy: cohort study. BMJ. 2014;348(5):g3361.
   PubMed Web of Science ®Google Scholar
• Coenders A, Koopmans NK, Broekhuijsen K, et al. Adjuvanted vaccines in pregnancy: no evidence for effect of the adjuvanted H1N1/09 vaccination on occurrence of preeclampsia or intra-uterine growth restriction. Eur J Obstet Gynecol Reprod Biol. 2015;187:14–19.
   PubMed Web of Science ®Google Scholar
• Fabiani M, Bella A, Rota MC, et al. A/H1N1 pandemic influenza vaccination: A retrospective evaluation of adverse maternal, fetal and neonatal outcomes in a cohort of pregnant women in Italy. Vaccine. 2015;33(19):2240–2247.
   PubMed Web of Science ®Google Scholar
• van der Maas N, Dijs-Elsinga J, Kemmeren J, et al. Safety of vaccination against influenza A (H1N1) during pregnancy in the Netherlands: results on pregnancy outcomes and infant’s health: cross-sectional linkage study. BJOG: Int J Obstet Gy. 2016;123(5):709–717.
   PubMed Web of Science ®Google Scholar
• Honda-Okubo Y, Saade F, Petrovsky N. Advax™, a polysaccharide adjuvant derived from delta inulin, provides improved influenza vaccine protection through broad-based enhancement of adaptive immune responses. Vaccine. 2012;30(36):5373–5381.
   PubMed Web of Science ®Google Scholar
• Gordon DL, Sajkov D, Woodman RJ, et al. Randomized clinical trial of immunogenicity and safety of a recombinant H1N1/2009 pandemic influenza vaccine containing Advax™ polysaccharide adjuvant. Vaccine. 2012;30(36):5407–5416.
   PubMed Web of Science ®Google Scholar
• Honda-Okubo Y, Kolpe A, Li L, et al. A single immunization with inactivated H1N1 influenza vaccine formulated with delta inulin adjuvant (Advax™) overcomes pregnancy-associated immune suppression and enhances passive neonatal protection. Vaccine. 2014;32(36):4651–4659.
   PubMed Web of Science ®Google Scholar
• Nordin JD, Kharbanda EO, Benitez GV, et al. Maternal safety of trivalent inactivated influenza vaccine in pregnant women. Obstet Gynecol. 2013;121(3):519–525.
   PubMed Web of Science ®Google Scholar
• Walsh LK, Donelle J, Dodds L, et al. Health outcomes of young children born to mothers who received 2009 pandemic H1N1 influenza vaccination during pregnancy: retrospective cohort study. BMJ. 2019;366:l4151.
   PubMed Web of Science ®Google Scholar
• Hviid A, Svanström H, Mølgaard-Nielsen D, et al. Association between Pandemic influenza A(H1N1) vaccination in pregnancy and early childhood morbidity in offspring. JAMA Pediatr. 2017;171(3):239–248.
   PubMed Web of Science ®Google Scholar
• Zimmermann P, Perrett KP, Messina NL, et al. The effect of maternal immunisation during pregnancy on infant vaccine responses. EClinicalMedicine. 2019;13:21–30.
   PubMedGoogle Scholar
• Fell DB, Bhutta ZA, Hutcheon JA, et al. Report of the WHO technical consultation on the effect of maternal influenza and influenza vaccination on the developing fetus: Montreal, Canada, September 30–October 1, 2015. Vaccine. 2017;35(18):2279–2287.
   PubMed Web of Science ®Google Scholar
• Naidu MA, Muljadi R, Davies-Tuck ML, et al. The optimal gestation for pertussis vaccination during pregnancy: a prospective cohort study. Am J Obstet Gynecol. 2016;215(2):237.e1–237.e6.
   Web of Science ®Google Scholar
• Abu Raya B, Srugo I, Kessel A, et al. The effect of timing of maternal tetanus, diphtheria, and acellular pertussis (Tdap) immunization during pregnancy on newborn pertussis antibody levels – a prospective study. Vaccine. 2014;32(44):5787–5793.
   PubMed Web of Science ®Google Scholar
• Kirkland KB, Talbot EA, Decker MD, et al. Kinetics of pertussis immune responses to tetanus-diphtheria-acellular pertussis vaccine in health care personnel: implications for outbreak control. Clin Infect Dis. 2009;49(4):584–587.
   PubMed Web of Science ®Google Scholar
• Halperin BA, Morris A, Mackinnon-Cameron D, et al. Kinetics of the antibody response to tetanus-diphtheria-acellular pertussis vaccine in women of childbearing age and postpartum women. Clin Infect Dis. 2011;53(9):885–892.
   PubMed Web of Science ®Google Scholar
• Wanlapakorn N, Maertens K, Chaithongwongwatthana S, et al. Assessing the reactogenicity of Tdap vaccine administered during pregnancy and antibodies to Bordetella pertussis antigens in maternal and cord sera of Thai women. Vaccine. 2018;36(11):1453–1459.
   PubMed Web of Science ®Google Scholar
• Huygen K, Caboré RN, Maertens K, et al. Humoral and cell mediated immune responses to a pertussis containing vaccine in pregnant and nonpregnant women. Vaccine. 2015;33(33):4117–4123.
   PubMed Web of Science ®Google Scholar
• Public Health England. Pertussis Vaccination Programme for Pregnant Women. Vaccine coverage estimates in England, April to September 2016. Vol. 10; 2016 25 November. Health Protection Report [Internet]; 2019 [cited 2019 June 3]. Available from: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/572731/hpr4116_prntl-prtsss-vc.pdf.
   Google Scholar
• Tomovici A, Barreto L, Zickler P, et al. Humoral immunity 10 years after booster immunization with an adolescent and adult formulation combined tetanus, diphtheria, and 5-component acellular pertussis vaccine. Vaccine. 2012;30(16):2647–2653.
   PubMed Web of Science ®Google Scholar
• Booy R, Van der Meeren O, Ng SP, et al. A decennial booster dose of reduced antigen content diphtheria, tetanus, acellular pertussis vaccine (Boostrix™) is immunogenic and well tolerated in adults. Vaccine. 2010;29(1):45–50.
   PubMed Web of Science ®Google Scholar
• Weston W, Messier M, Friedland LR, et al. Persistence of antibodies 3 years after booster vaccination of adults with combined acellular pertussis, diphtheria and tetanus toxoids vaccine. Vaccine. 2011;29(47):8483–8486.
   PubMed Web of Science ®Google Scholar
• Blanchard-Rohner G, Meier S, Bel M, et al. Influenza vaccination given at least 2 weeks before delivery to pregnant women facilitates transmission of seroprotective influenza-specific antibodies to the newborn. Pediatr Infect Dis J. 2013;32(12):1374–1380.
   PubMed Web of Science ®Google Scholar
• Horiya M, Hisano M, Iwasaki Y, et al. Efficacy of double vaccination with the 2009 pandemic influenza A (H1N1) vaccine during pregnancy. Obstet Gynecol. 2011;118(4):887–894.
   PubMed Web of Science ®Google Scholar
• Cuningham W, Geard N, Fielding JE, et al. Optimal timing of influenza vaccine during pregnancy: A systematic review and meta-analysis. Influ Other Respir Viruses. 2019;13(5):438–452.
   PubMed Web of Science ®Google Scholar
• Schlaudecker EP, Ambroggio L, McNeal MM, et al. Declining responsiveness to influenza vaccination with progression of human pregnancy. Vaccine. 2018;36(31):4734–4741.
   PubMed Web of Science ®Google Scholar
• Zhong Z, Haltalli M, Holder B, et al. The impact of timing of maternal influenza immunization on infant antibody levels at birth. Clin Exp Immunol. 2019;195(2):139–152.
   PubMed Web of Science ®Google Scholar
• Kahn KE, Black CL, Ding H, et al. Pregnant women and Tdap vaccination, Internet Panel survey, United States; April 2017 [updated 2018 May 8; cited 2019 July 30]. Available from: https://www.cdc.gov/vaccines/imz-managers/coverage/adultvaxview/pubs-resources/tdap-report-2017.html#footnotes.
   Google Scholar
• Laenen J, Roelants M, Devlieger R, et al. Influenza and pertussis vaccination coverage in pregnant women. Vaccine. 2015;33(18):2125–2131.
   PubMed Web of Science ®Google Scholar
• Maertens K, Braeckman T, Top G, et al. Maternal pertussis and influenza immunization coverage and attitude of health care workers towards these recommendations in Flanders, Belgium. Vaccine. 2016;34(47):5785–5791.
   PubMed Web of Science ®Google Scholar
• Maertens K, Braeckman T, Blaizot S, et al. Coverage of recommended vaccines during pregnancy in Flanders, Belgium. Fairly good but can we do better? Vaccine. 2018;36(19):2687–2693.
   PubMed Web of Science ®Google Scholar
• Public Health England. Pertussis vaccination programme for pregnant women update: vaccine coverage in England, January to March 2019 and 2018/19 annual coverage. Vol. 13; 2019 26 July. Health Protection Report [Internet]; 2019 [cited 2019 August 4]. Available from: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/821145/hpr2619_prntl-prtsss_VC.pdf.
   Google Scholar
• Ding H, Black CL, Ball S, et al. Influenza vaccination coverage among pregnant women – United States, 2016–17 influenza season. MMWR Morb Mortal Wkly Rep. 2017;66(38):1016–1022.
   PubMed Web of Science ®Google Scholar
• Ministero della Salute. Circolare 21 novembre 2018. Vaccinazioni raccomandate per le donne in età fertile e in gravidanza; 2019 [cited 2019 July 29]. Available from: http://www.trovanorme.salute.gov.it/norme/renderNormsanPdf?anno=2018&codLeg=66751&parte=1%20&serie=null.
   Google Scholar
• Winter K, Nickell S, Powell M, et al. Effectiveness of prenatal versus postpartum tetanus, diphtheria, and acellular pertussis vaccination in preventing infant pertussis. Clin Infect Dis. 2017;64(1):3–8.
   PubMed Web of Science ®Google Scholar
• CDC. Influenza (flu). Centers for Disease Control and Prevention; 2019 [updated 2019 February 4; cited 2019 May 21]. Available from: https://www.cdc.gov/breastfeeding/breastfeeding-special-circumstances/maternal-or-infant-illnesses/influenza.html.
   Google Scholar
• Watson JC, Hadler SC, Dykewicz CA, et al. Measles, mumps, and rubella – vaccine use and strategies for elimination of measles, rubella, and congenital rubella syndrome and control of mumps: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 1998;47(Rr-8):1–57.
   PubMedGoogle Scholar
• Valeggia C, Ellison PT. Interactions between metabolic and reproductive functions in the resumption of postpartum fecundity. Am J Hum Biol. 2009;21(4):559–566.
   PubMed Web of Science ®Google Scholar
• CDC. General recommendations on immunization – recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2011;60(2):1–64.
   Google Scholar
• Mitchell LA, Tingle AJ, MacWilliam L, et al. HLA-DR class II associations with rubella vaccine-induced joint manifestations. J Infect Dis. 1998;177(1):5–12.
   PubMed Web of Science ®Google Scholar
• Mitchell LA, Tingle AJ, Grace M, et al. Rubella virus vaccine associated arthropathy in postpartum immunized women: influence of preimmunization serologic status on development of joint manifestations. J Rheumatol. 2000;27(2):418–423.
   PubMed Web of Science ®Google Scholar
• Tingle AJ, Mitchell LA, Grace M, et al. Randomised double-blind placebo-controlled study on adverse effects of rubella immunisation in seronegative women. Lancet. 1997;349(9061):1277–1281.
   PubMed Web of Science ®Google Scholar
• Tingle AJ, Chantler JK, Pot KH, et al. Postpartum rubella immunization: association with development of prolonged arthritis, neurological sequelae, and chronic rubella viremia. J Infect Dis. 1985;152(3):606–612.
   PubMed Web of Science ®Google Scholar
• Slater PE, Ben-Zvi T, Fogel A, et al. Absence of an association between rubella vaccination and arthritis in underimmune postpartum women. Vaccine. 1995;13(16):1529–1532.
   PubMed Web of Science ®Google Scholar
• Ray P, Black S, Shinefield H, et al. Risk of chronic arthropathy among women after rubella vaccination. Vaccine Safety Datalink Team. JAMA. 1997;278(7):551–556.
   PubMed Web of Science ®Google Scholar
• Alzeidan RA, Wahabi HA, Fayed AA, et al. Postpartum rubella vaccination for sero-negative women. Cochrane Database Syst Rev. 2013;9. doi: 10.1002/14651858.CD010752
   Google Scholar
• Wong CY, Thomas NJ, Clarke M, et al. Maternal uptake of pertussis cocooning strategy and other pregnancy related recommended immunizations. Hum Vaccin Immunother. 2015;11(5):1165–1172.
   PubMed Web of Science ®Google Scholar
• Schatz M, Chambers CD, Jones KL, et al. Safety of influenza immunizations and treatment during pregnancy: the vaccines and medications in Pregnancy Surveillance System. Am J Obstet Gynecol. 2011;204(6):S64–S68.
   PubMed Web of Science ®Google Scholar
• Naleway AL, Ball S, Kwong JC, et al. Estimating vaccine effectiveness against hospitalized influenza during pregnancy: multicountry protocol for a retrospective cohort study. JMIR Res Protoc. 2019;8(1):e11333.
   PubMed Web of Science ®Google Scholar
• Shimabukuro TT, Nguyen M, Martin D, et al. Safety monitoring in the Vaccine Adverse Event Reporting System (VAERS). Vaccine. 2015;33(36):4398–4405.
   PubMed Web of Science ®Google Scholar
• DeStefano F. Vaccine Safety Datalink Research Group. The Vaccine Safety Datalink project. Pharmacoepidem Drug Safe.. 2001;10(5):403–406.
   PubMed Web of Science ®Google Scholar
• Baggs J, Gee J, Lewis E, et al. The Vaccine Safety Datalink: a model for monitoring immunization safety. Pediatrics. 2011;127:S45–S53.
   PubMed Web of Science ®Google Scholar
• Moro PL, McNeil MM, Sukumaran L, et al. The Centers for Disease Control and Prevention’s public health response to monitoring Tdap safety in pregnant women in the United States. Hum Vaccin Immunother. 2015;11(12):2872–2879.
   PubMed Web of Science ®Google Scholar
• Jones CE, Munoz FM, Spiegel HM, et al. Guideline for collection, analysis and presentation of safety data in clinical trials of vaccines in pregnant women. Vaccine. 2016;34(49):5998–6006.
   PubMed Web of Science ®Google Scholar
• Jones CE, Munoz FM, Kochhar S, et al. Guidance for the collection of case report form variables to assess safety in clinical trials of vaccines in pregnancy. Vaccine. 2016;34(49):6007–6014.
   PubMed Web of Science ®Google Scholar
• Bonhoeffer J, Kochhar S, Hirschfeld S, et al. Global alignment of immunization safety assessment in pregnancy – the GAIA project. Vaccine. 2016;34(49):5993–5997.
   PubMed Web of Science ®Google Scholar
• Munoz FM, Eckert LO, Katz MA, et al. Key terms for the assessment of the safety of vaccines in pregnancy: results of a global consultative process to initiate harmonization of adverse event definitions. Vaccine. 2015;33(47):6441–6452.
   PubMed Web of Science ®Google Scholar
• Committee for Medicinal Products for Human Use (CHMP), European Medicines Agency (EMEA). Guideline on the exposure to medicinal products during pregnancy: need for post-authorisation data; 2005 November 14 [cited 2019 July 1]. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Regulatory_and_procedural_guideline/2009/11/WC500011303.pdf.
   Google Scholar
• Roberts JN, Gruber MF. Regulatory considerations in the clinical development of vaccines indicated for use during pregnancy. Vaccine. 2015;33(8):966–972.
   PubMed Web of Science ®Google Scholar
• CDC. Recommended adult immunization schedule. USA: United States Centers for Disease Control and Prevention; 2019 February 19 [cited 2019 June 29]. Available from: https://www.cdc.gov/vaccines/schedules/downloads/adult/adult-combined-schedule.pdf.
   Google Scholar